Study: Too many seniors are back in hospital for infections treated during initial stay

The most common type of pre-existing infection in the patients was C. difficile


The rate of hospital readmissions for seniors with infections that were first treated during their initial hospital stay is too high, according to new research.

As many as 5 percent of patients leaving the hospital with an infection have a readmission for that pre-existing infection, according to an article on the U.S. News website.

A team analyzed Medicare data on more than 318,000 hospital discharges for patients aged 65 and older. Overall, 2.5% of them were readmitted for a pre-existing infection.

The most common type of pre-existing infection in the patients was C. difficile (about a 5% readmission rate) followed by urinary tract infections (2.4% readmission rate).

Read the article.

 



November 5, 2019


Topic Area: Infection Control


Recent Posts

Design-Build Benefits: Shorter Timeframe and Lower Costs Short

Upgrades at Grady Memorial ICU minimize patient disruption and revenue loss.


Norton West Louisville Hospital Opens in Kentucky

The facility is the first new hospital west of 9th Street in more than 150 years.


Man Wanted for Murder Captured at Hospital in South Carolina

A hospital employee identified the wanted man and alerted the authorities.


Infection Preventionist Staffing Levels Correlate to HAI Incidence

Nearly four in five hospitals are not staffed at sufficient levels to keep patients safe from preventable infections, according to a study.


SW Family Medicine Experiences Cyber Incident

The incident occurred on or about August 7, 2024.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.